18
Julian Seago Improving quality assurance of FMD vaccine production

Julian Seago Improving quality assurance of FMD vaccine production

Embed Size (px)

Citation preview

Page 1: Julian Seago Improving quality assurance of FMD vaccine production

Julian Seago

Improving quality assurance of

FMD vaccine production

Page 2: Julian Seago Improving quality assurance of FMD vaccine production

• Intact capsids (146S) are required to generate neutralising antibodies

• FMDV is both pH and temperature labile.

• Serotype differences: A and Asia1 are relatively more stable than O and SAT serotypes.

• Chemical inactivation renders the FMDV capsid less stable

WHY MONITOR FMDV CAPSID STABILITY?

Page 3: Julian Seago Improving quality assurance of FMD vaccine production

Thermofluor assay: a simple, fast method to analyse capsid stability

Minimal requirements: •qPCR machine •Fluorescent dye that binds RNA genome – SYBR green II •Virus sample

Methodology:

As temperature increases the FMDV capsid dissociates and releases the viral genome (TR = release temperature), which is bound by the Fluorescent dye.

THERMOFLUOR ANALYSIS

Page 4: Julian Seago Improving quality assurance of FMD vaccine production

-1052 = 53.5oC

53.5oC TR = Inflection point of slope

TR = Most negative

Raw fluorescence signal

Neg. derivative fluorescence signal

THERMOFLUOR ANALYSIS

Page 5: Julian Seago Improving quality assurance of FMD vaccine production

POTENTIAL APPLICATIONS FOR THERMOFLUOR

Analysis of stabilising mutations

Screening solutions for their ability to stabilise capsids

Comparing stability of different strains

Monitoring stability during vaccine production

Can all be used to produce better vaccines ……….

Page 6: Julian Seago Improving quality assurance of FMD vaccine production

O1M

Stabilised FMDV capsids

Page 7: Julian Seago Improving quality assurance of FMD vaccine production

QUALITY CONTROL DURING FMDVACCINE PRODUCTION

1 2 3

Page 8: Julian Seago Improving quality assurance of FMD vaccine production

Purified FMDV

VP1VP2 & 3

VP4

SIMPLIFY SAMPLE PREPARATION

Unpurified FMDV

Page 9: Julian Seago Improving quality assurance of FMD vaccine production

THERMOFLUOR ANALYSIS USING LIVE VIRUS

Page 10: Julian Seago Improving quality assurance of FMD vaccine production

THERMOFLUOR ANALYSIS

Page 11: Julian Seago Improving quality assurance of FMD vaccine production

THERMOFLUOR ANALYSIS USING INACTIVATED VIRUS

Page 12: Julian Seago Improving quality assurance of FMD vaccine production

THERMOFLUOR ANALYSIS USING FORMULATED VACCINE

ISA 206 produces a double emulsion vaccine

Page 13: Julian Seago Improving quality assurance of FMD vaccine production

THERMOFLUOR ANALYSIS OF STORED VACCINE

Page 14: Julian Seago Improving quality assurance of FMD vaccine production

STORAGE OF UNFORMULATED VACCINE (O K 77/78)

Page 15: Julian Seago Improving quality assurance of FMD vaccine production

STORAGE OF ISA 206 FORMULATED VACCINE (O K 77/78)

Page 16: Julian Seago Improving quality assurance of FMD vaccine production

STORAGE OF ISA 201 FORMULATED VACCINE (O K 77/78)

Page 17: Julian Seago Improving quality assurance of FMD vaccine production

SUMMARY

• The thermofluor assay can be used to assess stability of non-purified infectious virus, as well as unformulated and formulated inactivated virus (vaccine).

• The thermofluor assay offers a new tool for quality assurance at different stages of FMD vaccine production.

Page 18: Julian Seago Improving quality assurance of FMD vaccine production

The Pirbright Institute

Bryan Charleston

Eva Perez

Valérie Mioulet

Nick Lyons

Veronica Carr

ACKNOWLEDGEMENTS